About Mount Sinai Medical Center
Founded in 1852, Mount Sinai Hospital is a 1,171-bed tertiary-care center known for its excellence in clinical care. Mount Sinai is a National Cancer Institute (NCI)-Designated cancer center and is able to offer the most advanced treatments for patients with all types of cancer.
The distinguished team provides exceptional medical, surgical, radiation oncology, as well as emerging treatment options, such as immunotherapy services across the New York metropolitan area.
Treatment plans for mesothelioma, under the direction of Chairman of the Department of Thoracic Surgery, Dr. Raja M. Flores, consists of a team of specialists including:
- Thoracic surgeons
- Medical oncologists
- Radiation oncologists
These specialists review each patient’s case to develop a comprehensive plan of treatment.
Mount Sinai Medical Center Location and Overview
- Large hospital located in Manhattan, New York City, overlooking the famous Central Park
- Consistently earns Magnet Status for excellence in nursing care
- Recognized for opening the first geriatric emergency room in the state
- Home to the World Trade Center Health Program Clinical Center of Excellence, which provides long-term medical assistance to those affected by the 9/11 terrorist attack in New York City
Mount Sinai Medical Center is located at:
One Gustave L. Levy Place
New York, NY 10029
Patient Experience at Mount Sinai
At Mount Sinai, specialists in thoracic surgery, pulmonary medicine and medical/radiation oncology collaborate to develop an individualized treatment plan for each patient.
This includes a full-range of mesothelioma treatment options such as surgical intervention as well as non-surgical treatment options such as radiation therapy and chemotherapy. Minimally invasive interventions are preferred whenever possible. Mesothelioma is a complex disease that requires close collaboration among all doctors on the team.
In addition to medical treatment, Mount Sinai offers a multitude of complementary and supportive treatments such as:
- Pain management
- Social work
- Psychological services
Mount Sinai strongly believes in treating the patient, not the disease. All aspects of care are easily coordinated among all specialties in one central location.
Mesothelioma Program at Mount Sinai Medical Center
At Mount Sinai’s mesothelioma program, under the umbrella of Lung and Thoracic Cancer department, the treatment plan is individualized for each patient, combining multiple modalities including surgery, chemotherapy and radiation. The principal goal of treatment is to optimize the quality of life and treatment plan will differ from patient to patient.
One of the foremost experts in the treatment of mesothelioma, Dr. Flores, has more than 15 years of experience treating it. Dr. Flores is a strong advocate for lung-sparing techniques which aim to preserve the underlying lung if surgical treatment is warranted.
Dr. Flores is a recognized leader in the Thoracic Surgery realm for his pioneering efforts in mesothelioma treatment. He has established the VATS procedure—minimally invasive surgery using a few incisions—as the gold standard in surgical treatment of lung cancer.
He currently has one of the largest VATS lobectomy experiences in the world and has published important research data, which he has presented at numerous national and international meetings.
Mount Sinai’s Lung and Thoracic Center also works in conjunction with The Selikoff Centers for Occupational Health to partner on mesothelioma issues. This center specializes in treating injuries and illnesses that have occurred or have been made worse by an exposure or event in the workplace.
Mesothelioma Doctors at Mount Sinai Medical Center
Mesothelioma patients visiting Mount Sinai Medical Center will receive multidisciplinary treatment from the following specialists:
- Raja M. Flores
- E. Neil Schachter, MD
- Steven D Herman, MD
- Andrew J Kaufman, MD
- Dong-Seok Lee, MD
- Daniel G Nicastri, MD
- Wissam N Raad, MD
- Andrea Wolf, MD
Mesothelioma Treatment Options at Mount Sinai Medical Center
Patients undergoing mesothelioma intervention at Mount Sinai Medical Center may undergo any of the following targeted treatment combinations:
- Extrapleural Pneumonectomy: Surgical procedure that involves removing the lung in addition to the lining.
- Pleurectomy/Decortication: Surgical procedure that involves removing only the lining and preserving the lung.
- Radiation Oncology: Mount Sinai’s specialists are pioneering the development of new technologies to deliver the precise dosage of radiation to lung tumors at certain points in the respiration cycle. These treatments help to shorten treatment, preserve healthy tissue and increase radiation dose safely.
- Stereotactic Body Radiation Therapy: This therapy delivers high doses of radiation directly to the lung tumor. The doctor and radiation therapist review body scans right before treatment to ensure the radiation goes to the right place.
- Internal Radiation Therapy (Brachytherapy): During this therapy, radioactive material is placed directly into the tumor. Brachytherapy directly targets the tumor while protecting nearby organs from exposure.
Chemotherapies and Medical Oncology
Mount Sinai Medical Center is constantly at the forefront of using and developing innovative effective chemotherapies. Thoracic medical oncology specialists are aiming to develop new medical therapies for cancer that are less toxic with fewer side effects but equally, if not more, effective than existing therapies.
Mount Sinai’s goal is to provide the latest treatments that research and science have to offer.
They are focusing on new and different ways to combat lung and chest cancers by:
- Researching new immunological treatments like vaccinations
- Studying the basic biology of lung cancer itself
- Staying up-to-date with research being performed at other centers
Mount Sinai is also using a new class of medications known as molecular targeted therapy, which blocks the signals that encourage cancer cells to grow and spread
Clinical Trials and Research at Mount Sinai Medical Center
The mesothelioma team at Mount Sinai is heavily involved in research comparing extrapleural pneumonectomy and pleurectomy/decortication for treating mesothelioma. Additionally, the physicians are active in other mesothelioma research ranging from molecular research to participation in clinical trials.
The physicians at Mount Sinai regularly contribute to the National Mesothelioma Virtual Bank, which provides a catalog of categorized, searchable tumors to investigate the disease process of mesothelioma and potential targeted therapies.
Dr. Flores is the Principle Investigator of the Libby Epidemiology Research Program—a $4.8 million grant funded by the Agency for Toxic Substances and Disease Registry (ATSDR). The goals of the research include uncovering the answers to the health consequences of asbestos exposure.
Mount Sinai Medical Center Insurance Information
The hospitals in the Mount Sinai Health System are participating providers in many health care plans. There are dozens of health insurance plans accepted at Mount Sinai Hospital.
Mount Sinai’s Patient Financial Services team is dedicated to working with you to:
- Interpret insurance coverage
- Verify eligibility and benefits
- Coordinate with the insurance provider to obtain authorization for emergency inpatient admissions
- Investigate alternative payment sources that may be available to you such as Medicaid or charity assistance programs
- Make payment arrangements
To reach Billing and Patient Financial Services, call 212-731-3100 or toll-free at 866-682-9380.
Seeking Treatment at Mount Sinai Medical Center
Mount Sinai Medical Center is paving the way with new and innovative treatments for mesothelioma. Those wishing to start their mesothelioma treatment at this state-of-the-art facility should call (212) 241-9466 to make an appointment.